Abstract

TThe molecular mechanisms responsible for the development of hepatic fibrosis are not fully understood. The Nlrc4 inflammasome detects cytosolic presence of bacterial components, activating inflammatory cytokines to facilitate clearance of pathogens and infected cells. We hypothesized that low-grade constitutive activation of the Nlrc4 inflammasome may lead to induced hepatocyte proliferation and prevent the development of hepatic fibrosis. The gene of Nlrc4 contains two single nucleotide polymorphisms (SNPs), one located within the Nlrc4 promoter and one contained within exon 5. These SNPs regulate Nlrc4 gene transcription and activation as measured through gene reporter assays and IL-1β secretion. The 17C-6 mice have increased IL-1β in plasma after chronic carbon tetrachloride (CCl4) administration compared to B6 mice. After two-thirds partial hepatectomy (2/3PH) 17C-6 mice have earlier restoration of liver mass with greater cyclin D1 protein and BrdU incorporation compared to B6 mice at several time points. These data reveal mild constitutive activation of the Nlrc4 inflammasome as the results of two SNPs, which leads to the stimulation of hepatocyte proliferation. The increased liver regeneration induces rapid liver mass recovery after hepatectomy and may prevent the development of hepatotoxin-induced liver fibrosis.

Highlights

  • Nonalcoholic fatty liver disease (NAFLD) has become a significant cause of chronic liver disease with staggering occurrence in the USA and worldwide [1]

  • Chromatin Immunoprecipitation (ChIP) analysis revealed transcription factor Cdx-1 binds to the mouse Nlrc4 promoter at 3 potential Cdx-1 binding sites but not at the region of the SNP (Figure 2, Supplemental Figure 1)

  • Within 17C-6 mice we found a statistical increase in mRNA levels of IL-1β, IL-18, tumor necrosis factor α (TNF-α), and IκBα

Read more

Summary

Introduction

Nonalcoholic fatty liver disease (NAFLD) has become a significant cause of chronic liver disease with staggering occurrence in the USA and worldwide [1]. NAFLD is a term used to label a spectrum of liver diseases ranging from early stage fatty liver (steatosis) to advanced cirrhosis of the liver and hepatocellular carcinoma [10]. This disease is aptly named as it occurs in individuals who consume little to no alcohol and the NAFLD pathology closely resembles that of a diseased liver attributable to alcohol abuse [11]. NAFLD is believed to originate with the accumulation of fatty acids within the liver as a result of insulin resistance [12]. Genetic factors contribute to an individual’s predisposition to the development and progression of NAFLD [15]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call